Carcinogenesis, Vol. 20, No. 6, 1085-1089,
June 1999
© 1999 Oxford University Press
Carcinogenesis |
Use of UvrABC nuclease to quantify benzo[a]pyrene diol epoxide–DNA adduct formation at methylated versus unmethylated CpG sites in the p53 gene
Department of Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Science Park, Smithville, TX 78957, USA and
1 Department of Biology, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA
We have used the UvrABC nuclease incision method in combination with ligation-mediated polymerase chain reaction (LMPCR) techniques to map and quantify (±)anti-7ß, 8
-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]-pyrene (BPDE) adduct formation in the p53 gene of human cells. We found that BPDE adduct formation, as revealed by UvrABC incision, preferentially occurred at methylated CpG sites that correspond to the mutational hotspots observed in human lung cancers. Our hypothesis is that it is this methylated CpG sequence-dependent preferential adduct formation, rather than selective growth advantage, that is the major determinant of the p53 mutation pattern in human cancers. Given the far reaching ramifications of such conclusions for cancer etiology, a legitimate question is raised regarding the reliability of using the UvrABC incision method for quantifying and determining the sequence-dependency of adduct formation. Is the higher frequency of UvrABC cutting at methylated versus unmethylated CpG sites due to the preference of the nuclease for cutting at those sites or due to the preferential formation of BPDE adducts at those sites? In order to distinguish between these two possibilities, we have analyzed the kinetics of UvrABC incision at BPDE adducts formed at either methylated CpG sites versus other sequences, or unmethylated CpG sites versus other sequences in exon 5 of the p53 gene. We have found that the UvrABC cutting kinetics are identical for both cases. On the basis of these results we conclude that under proper cutting conditions, UvrABC nuclease reacts with and incises with equal efficiency, BPDE adducts formed at methylated or unmethylated CpG sites as well as other sequences, and that the extent of UvrABC incision accurately reflects the extent of BPDE–DNA adduct formation. These conclusions were further supported by results obtained using a DNA synthesis blockage assay.
Abbreviations: BPDE, (±)anti-7ß,8-dihydroxy-9,10-epoxy-7,8,9,10-tetra-hydrobenzo[a]pyrene; DTT, dithiothreitol; LMPCR, ligation-mediated polymerase chain reaction.
2 To whom correspondence should be addressed Email: sa83103{at}odin.mdacc.tmc.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. J. Evison, R. A. Bilardi, F. C. K. Chiu, G. Pezzoni, D. R. Phillips, and S. M. Cutts CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity Nucleic Acids Res., October 1, 2009; 37(19): 6355 - 6370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Rudin, E. Avila-Tang, C. C. Harris, J. G. Herman, F. R. Hirsch, W. Pao, A. G. Schwartz, K. H. Vahakangas, and J. M. Samet Lung Cancer in Never Smokers: Molecular Profiles and Therapeutic Implications Clin. Cancer Res., September 15, 2009; 15(18): 5646 - 5661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Yoon, A. Besaratinia, Z. Feng, M.-s. Tang, S. Amin, A. Luch, and G. P. Pfeifer DNA Damage, Repair, and Mutation Induction by (+)-Syn and (-)-Anti-Dibenzo[a,l]Pyrene-11,12-Diol-13,14-Epoxides in Mouse Cells Cancer Res., October 15, 2004; 64(20): 7321 - 7328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Feng, W. Hu, W. N. Rom, M. Costa, and M.-S. Tang Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in human lung cells Carcinogenesis, April 1, 2003; 24(4): 771 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Feng, W. Hu, J. X. Chen, A. Pao, H. Li, W. Rom, M.-C. Hung, and M.-s. Tang Preferential DNA Damage and Poor Repair Determine ras Gene Mutational Hotspot in Human Cancer J Natl Cancer Inst, October 16, 2002; 94(20): 1527 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Feng, W. Hu, W. N. Rom, F. A. Beland, and M.-s. Tang 4-Aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene Carcinogenesis, October 1, 2002; 23(10): 1721 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Yoon, L. E. Smith, Z. Feng, M.-s. Tang, C.-S. Lee, and G. P. Pfeifer Methylated CpG Dinucleotides Are the Preferential Targets for G-to-T Transversion Mutations Induced by Benzo[a]pyrene Diol Epoxide in Mammalian Cells: Similarities with the p53 Mutation Spectrum in Smoking-associated Lung Cancers Cancer Res., October 1, 2001; 61(19): 7110 - 7117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F Costello and C. Plass Methylation matters J. Med. Genet., May 1, 2001; 38(5): 285 - 303. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Smela, S. S. Currier, E. A. Bailey, and J. M. Essigmann The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis Carcinogenesis, April 1, 2001; 22(4): 535 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Arlt, H. H. Schmeiser, and G. P. Pfeifer Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR Carcinogenesis, January 1, 2001; 22(1): 133 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Smith, M. F. Denissenko, W. P. Bennett, H. Li, S. Amin, M.-s. Tang, and G. P. Pfeifer Targeting of Lung Cancer Mutational Hotspots by Polycyclic Aromatic Hydrocarbons J Natl Cancer Inst, May 17, 2000; 92(10): 803 - 811. [Abstract] [Full Text] [PDF]
|
|